HomeREGULATORY
REGULATORY

4th or Later Players Could Also Qualify for PMP If Post-Launch “True Clinical Utility” Premium Granted: MHLW
(Dec.21.2017)

The Ministry of Health, Labor and Welfare (MHLW) intends to make fourth-to-market drugs or later products in a novel class eligible for the so-called price maintenance premium (PMP) if they win the premium for “true clinical utility” following their listing, ministry officials told reporters on December 20 ...
(LOG IN FOR FULL STORY)